Chronic obstructive pulmonary disease phenotypes: the future of COPD

…, SI Rennard, FC Sciurba, EK Silverman… - American journal of …, 2010 - atsjournals.org
Significant heterogeneity of clinical presentation and disease progression exists within
chronic obstructive pulmonary disease (COPD). Although FEV 1 inadequately describes this …

Genetic epidemiology of COPD (COPDGene) study design

…, TH Beaty, D Curran-Everett, EK Silverman… - COPD: Journal of …, 2011 - Taylor & Francis
Background: COPDGene is a multicenter observational study designed to identify genetic
factors associated with COPD. It will also characterize chest CT phenotypes in COPD subjects, …

[HTML][HTML] Characterisation of COPD heterogeneity in the ECLIPSE cohort

…, W MacNee, BE Miller, S Rennard, EK Silverman… - Respiratory …, 2010 - Springer
Background Chronic obstructive pulmonary disease (COPD) is a complex condition with
pulmonary and extra-pulmonary manifestations. This study describes the heterogeneity of …

An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease

…, D Postma, I Romieu, EK Silverman… - American journal of …, 2010 - atsjournals.org
Rationale: Although cigarette smoking is the most important cause of chronic obstructive
pulmonary disease (COPD), a substantial proportion of COPD cases cannot be explained by …

[HTML][HTML] Changes in forced expiratory volume in 1 second over time in COPD

…, W MacNee, BE Miller, EK Silverman… - … England Journal of …, 2011 - Mass Medical Soc
Background A key feature of chronic obstructive pulmonary disease (COPD) is an accelerated
rate of decline in forced expiratory volume in 1 second (FEV 1 ), but data on the variability …

[HTML][HTML] Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype

…, E Wouters, C Crim, JC Yates, EK Silverman… - PloS one, 2012 - journals.plos.org
Background Because chronic obstructive pulmonary disease (COPD) is a heterogeneous
condition, the identification of specific clinical phenotypes is key to developing more effective …

[HTML][HTML] A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci

…, SI Rennard, DA Lomas, EK Silverman… - PLoS …, 2009 - journals.plos.org
There is considerable variability in the susceptibility of smokers to develop chronic obstructive
pulmonary disease (COPD). The only known genetic risk factor is severe deficiency of α 1 -…

Inherited causes of clonal haematopoiesis in 97,691 whole genomes

…, M Fornage, S Redline, BM Psaty, EK Silverman… - Nature, 2020 - nature.com
Age is the dominant risk factor for most chronic human diseases, but the mechanisms
through which ageing confers this risk are largely unknown 1 . The age-related acquisition of …

The Effect of Polymorphisms of the β2-Adrenergic Receptor on the Response to Regular Use of Albuterol in Asthma

…, DE McLEAN, SP Peters, EK Silverman… - American journal of …, 2000 - atsjournals.org
Inhaled β -adrenergic agonists are the most commonly used medications for the treatment
of asthma although there is evidence that regular use may produce adverse effects in some …

[HTML][HTML] Patterns of growth and decline in lung function in persistent childhood asthma

…, KG Tantisira, EK Silverman… - … England Journal of …, 2016 - Mass Medical Soc
Background Tracking longitudinal measurements of growth and decline in lung function in
patients with persistent childhood asthma may reveal links between asthma and subsequent …